2 assets in Obesity Due To Leptin Receptor Gene Deficiency

Therapeutic assets addressing Obesity Due To Leptin Receptor Gene Deficiency, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Setmelanotide Obesity Due To Leptin Receptor Gene Deficiency	Rhythm Pharmaceuticals, Inc.	P3	BB (68)
lb54640 Obesity Due To Leptin Receptor Gene Deficiency	LG Chem	P2	CCC (53)